300434 金石亚药
已收盘 12-08 15:00:00
资讯
新帖
简况
金石亚药：公司积极布局保健品新零售领域
证券之星 · 12-01
金石亚药：公司积极布局保健品新零售领域
金石亚药：拥有快克、小快克等流感相关产品
证券之星 · 11-27
金石亚药：拥有快克、小快克等流感相关产品
金石亚药：快克清磷酸奥司他韦胶囊已获批
证券之星 · 11-12
金石亚药：快克清磷酸奥司他韦胶囊已获批
金石亚药(300434.SZ)获得硫酸氨基葡萄糖胶囊药品注册证书
智通财经 · 11-10
金石亚药(300434.SZ)获得硫酸氨基葡萄糖胶囊药品注册证书
金石亚药（300434）披露全资子公司药品通过仿制药一致性评价，11月04日股价上涨1.25%
证券之星 · 11-04
金石亚药（300434）披露全资子公司药品通过仿制药一致性评价，11月04日股价上涨1.25%
金石亚药(300434.SZ)：双氯芬酸钠缓释片通过一致性评价
智通财经 · 11-04
金石亚药(300434.SZ)：双氯芬酸钠缓释片通过一致性评价
11月3日金石亚药现1笔折价11.61%的大宗交易 合计成交990万元
证券之星 · 11-03
11月3日金石亚药现1笔折价11.61%的大宗交易 合计成交990万元
金石亚药（300434）2025年三季报简析：净利润同比增长66.47%，盈利能力上升
证券之星 · 10-25
金石亚药（300434）2025年三季报简析：净利润同比增长66.47%，盈利能力上升
金石亚药（300434）披露2025年三季度报告，10月23日股价下跌0.77%
证券之星 · 10-23
金石亚药（300434）披露2025年三季度报告，10月23日股价下跌0.77%
金石亚药(300434.SZ)发布前三季度业绩，归母净利润9676.59万元，增长66.47%
智通财经 · 10-23
金石亚药(300434.SZ)发布前三季度业绩，归母净利润9676.59万元，增长66.47%
股市必读：金石亚药（300434）预计2025年1-9月归属净利润盈利8660.55万元至1.07亿元
证券之星 · 10-20
股市必读：金石亚药（300434）预计2025年1-9月归属净利润盈利8660.55万元至1.07亿元
金石亚药(300434.SZ)发预增，预计前三季度净利润8660.55万元至1.07亿元，同比增长48.99%至83.95%
智通财经 · 10-17
金石亚药(300434.SZ)发预增，预计前三季度净利润8660.55万元至1.07亿元，同比增长48.99%至83.95%
股市必读：金石亚药（300434）10月9日董秘有最新回复
证券之星 · 10-10
股市必读：金石亚药（300434）10月9日董秘有最新回复
金石亚药：不涉及生产PBO材料
证券之星 · 09-17
金石亚药：不涉及生产PBO材料
股市必读：金石亚药中报 - 第二季度单季净利润同比增长105.72%
证券之星 · 08-29
股市必读：金石亚药中报 - 第二季度单季净利润同比增长105.72%
金石亚药：2025年上半年净利润同比增长67.71%
金融界 · 08-27
金石亚药：2025年上半年净利润同比增长67.71%
昨日化学制药行业主力净流出超25亿元，金石亚药、九典制药、科伦药业等靠前
制药网 · 07-31
昨日化学制药行业主力净流出超25亿元，金石亚药、九典制药、科伦药业等靠前
金石亚药：“快克泰”续断壮骨胶囊为国家中药二类新药
互动易 · 07-30
金石亚药：“快克泰”续断壮骨胶囊为国家中药二类新药
金石亚药：益今生胶囊目前正处于Ⅱ期临床研究阶段
证券之星 · 07-30
金石亚药：益今生胶囊目前正处于Ⅱ期临床研究阶段
金石亚药：公司重点产品为“小快克”小儿氨酚黄那敏颗粒
证券之星 · 07-30
金石亚药：公司重点产品为“小快克”小儿氨酚黄那敏颗粒
加载更多
公司概况
公司名称：
四川金石亚洲医药股份有限公司
所属行业：
医药制造业
上市日期：
2015-04-24
主营业务：
四川金石亚洲医药股份有限公司的主营业务是药品（包括化学药、中药饮片等）和保健食品（包括稀有人参皂苷产品和维生素矿物质补益类产品）的研发、生产与销售；增强塑料复合管道技术的研发和应用、真空镀膜设备的研发和制造。公司的主要产品是药品、保健食品、真空镀膜设备。
发行价格：
10.57
{"stockData":{"symbol":"300434","market":"SZ","secType":"STK","nameCN":"金石亚药","latestPrice":11.56,"timestamp":1765177437000,"preClose":11.71,"halted":0,"volume":17583080,"delay":0,"changeRate":-0.0128,"floatShares":342000000,"shares":401999999,"eps":0.3246,"marketStatus":"已收盘","change":-0.15,"latestTime":"12-08 15:00:00","open":11.7,"high":11.82,"low":11.48,"amount":204000000,"amplitude":0.029,"askPrice":11.56,"askSize":167,"bidPrice":11.55,"bidSize":415,"shortable":0,"etf":0,"ttmEps":0.3246,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.71,"symbolType":"stock","openAndCloseTimeList":[[1765157400000,1765164600000],[1765170000000,1765177200000]],"highLimit":12.88,"lowLimit":10.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401743872,"isCdr":false,"pbRate":1.87,"roa":"--","peRate":35.613062,"roe":"3.89%","epsLYR":0.23,"committee":0.436156,"marketValue":4644000000,"turnoverRate":0.0514,"status":1,"floatMarketCap":3955000000},"requestUrl":"/m/hq/s/300434","defaultTab":"news","newsList":[{"id":"2588740750","title":"金石亚药：公司积极布局保健品新零售领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2588740750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588740750?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:48","pubTimestamp":1764578889,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药12月01日在投资者关系平台上答复投资者关心的问题。公司积极布局保健品新零售领域，成功开拓了京东自营、阿里自营、京东旗舰店、拼多多旗舰店等多元化销售渠道。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100019180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0077","BK0239"],"gpt_icon":0},{"id":"2586294547","title":"金石亚药：拥有快克、小快克等流感相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2586294547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586294547?lang=zh_cn&edition=full","pubTime":"2025-11-27 08:54","pubTimestamp":1764204859,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药11月26日在投资者关系平台上答复投资者关心的问题。公司是国内感冒药一线产品“快克”和“小快克”的品牌缔造者和拥有者。此外，还有愈美甲麻敏糖浆、蒲地蓝消炎片、抗病毒口服液、复方金银花颗粒、感冒清热颗粒、布洛伪麻片、枇杷止咳颗粒、布洛芬颗粒、小儿咳喘灵颗粒、板蓝根颗粒等多个产品，满足消费者预防、缓解、治疗感冒的多方面需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700004357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0239","BK0028"],"gpt_icon":0},{"id":"2582348744","title":"金石亚药：快克清磷酸奥司他韦胶囊已获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348744","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582348744?lang=zh_cn&edition=full","pubTime":"2025-11-12 11:36","pubTimestamp":1762918599,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药11月11日在投资者关系平台上答复投资者关心的问题。公司全资子公司海南亚洲制药股份有限公司“快克清”磷酸奥司他韦胶囊已于去年10月获批，目前该产品销售已覆盖线下药店、线上平台，方便患者便捷购药。该药品主要成分为磷酸奥司他韦，用于成人及儿童甲型和乙型流感的治疗和预防。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200014590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300434"],"gpt_icon":0},{"id":"2582282128","title":"金石亚药(300434.SZ)获得硫酸氨基葡萄糖胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2582282128","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582282128?lang=zh_cn&edition=full","pubTime":"2025-11-10 17:45","pubTimestamp":1762767938,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)发布公告，近日，公司全资二级子公司浙江亚克药业有限公司(以下简称“亚克药业”)收到国家药品监督管理局核准签发的硫酸氨基葡萄糖胶囊《药品注册证书》，且视同通过一致性评价。硫酸氨基葡萄糖胶囊为镇痛类非处方药药品，适应症为原发性及继发性骨关节炎。氨基葡萄糖是一种天然的氨基单糖，是蛋白多糖合成的前体物质，可以刺激软骨细胞产生有正常多聚体结构的蛋白多糖，提高软骨细胞的修复能力，抑制损伤软骨的酶如胶原酶和磷脂酶A2，并可防止损伤细胞的超氧化自由基的产生，可以促进软骨基质的修复和重建，从而可延缓骨关节疼痛的病理过程和疾病的进程，改善关节活动，缓解疼痛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0028","300434","BK0239"],"gpt_icon":0},{"id":"2580753158","title":"金石亚药（300434）披露全资子公司药品通过仿制药一致性评价，11月04日股价上涨1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580753158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580753158?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:44","pubTimestamp":1762267466,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，金石亚药报收于11.34元，较前一交易日上涨1.25%，最新总市值为45.56亿元。公司近日发布公告称，其全资二级子公司浙江迪耳药业有限公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，双氯芬酸钠缓释片通过仿制药质量和疗效一致性评价。该药品原批准文号为国药准字H20083921，注册分类为化学药品，上市许可持有人为浙江迪耳药业有限公司。截至公告日，已有7家生产企业通过或视同通过该品种一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400039771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300434","BK0028"],"gpt_icon":0},{"id":"2580207102","title":"金石亚药(300434.SZ)：双氯芬酸钠缓释片通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2580207102","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580207102?lang=zh_cn&edition=full","pubTime":"2025-11-04 15:57","pubTimestamp":1762243034,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)公告，公司全资二级子公司浙江迪耳药业有限公司(简称“迪耳药业”)于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，迪耳药业双氯芬酸钠缓释片(0.1g规格)通过仿制药质量和疗效一致性评价。据公告信息所示，双氯芬酸钠缓释片的适应症为：缓解类风湿关节炎、骨关节炎、脊柱关节病、痛风性关节炎、风湿性关节炎等各种慢性关节炎的急性发作期或持续性的关节肿痛症状;各种软组织风湿性疼痛，如肩痛、腱鞘炎、滑囊炎、肌痛及运动后损伤性疼痛等;急性的轻、中度疼痛如：手术、创伤、劳损后等的疼痛，原发性痛经，牙痛，头痛等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0077","BK0028","300434"],"gpt_icon":0},{"id":"2580260076","title":"11月3日金石亚药现1笔折价11.61%的大宗交易 合计成交990万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580260076","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580260076?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:18","pubTimestamp":1762161503,"startTime":"0","endTime":"0","summary":"证券之星消息，11月3日金石亚药发生大宗交易，交易数据如下：大宗交易成交价格9.9元，相对当日收盘价折价11.61%，成交100万股，成交金额990万元，买方营业部为国泰海通证券股份有限公司成都天府二街第二证券营业部，卖方营业部为国泰海通证券股份有限公司成都天府二街第二证券营业部。截至2025年11月3日收盘，金石亚药报收于11.2元，上涨2.0%，换手率7.67%，成交量26.23万手，成交额2.91亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300023179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300434"],"gpt_icon":0},{"id":"2578257775","title":"金石亚药（300434）2025年三季报简析：净利润同比增长66.47%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578257775","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578257775?lang=zh_cn&edition=full","pubTime":"2025-10-25 06:09","pubTimestamp":1761343752,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金石亚药发布2025年三季报。截至本报告期末，公司营业总收入7.08亿元，同比下降6.37%，归母净利润9676.59万元，同比上升66.47%。本报告期金石亚药盈利能力上升，毛利率同比增幅2.96%，净利率同比增幅81.48%。去年的净利率为8.03%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"gpt_icon":0},{"id":"2577758335","title":"金石亚药（300434）披露2025年三季度报告，10月23日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577758335","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577758335?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:14","pubTimestamp":1761228856,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，金石亚药报收于11.57元，较前一交易日下跌0.77%，最新总市值为46.48亿元。近日，金石亚药发布《2025年第三季度报告》，披露了公司前三季度主要财务数据。经营活动产生的现金流量净额为151,576,205.80元，同比增长112.31%。此外，公告显示，公司2025年第三季度合并报表范围新增杭州迪耳医药科技有限公司、合肥市迪耳大药房有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300434","BK0028"],"gpt_icon":0},{"id":"2577230950","title":"金石亚药(300434.SZ)发布前三季度业绩，归母净利润9676.59万元，增长66.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577230950","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577230950?lang=zh_cn&edition=full","pubTime":"2025-10-23 19:51","pubTimestamp":1761220290,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)发布2025年三季度报告，该公司前三季度营业收入为7.08亿元，同比减少6.37%。归属于上市公司股东的净利润为9676.59万元，同比增长66.47%。归属于上市公司股东的扣除非经常性损益的净利润为7901.15万元，同比增长51.82%。基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金石亚药(300434.SZ)发布前三季度业绩，归母净利润9676.59万元，增长66.47%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300434"],"gpt_icon":0},{"id":"2576008031","title":"股市必读：金石亚药（300434）预计2025年1-9月归属净利润盈利8660.55万元至1.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576008031","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576008031?lang=zh_cn&edition=full","pubTime":"2025-10-20 03:12","pubTimestamp":1760901132,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，金石亚药报收于9.76元，下跌1.81%，换手率2.33%，成交量7.96万手，成交额7854.21万元。来自业绩披露要点：金石亚药预计2025年前三季度归母净利润同比增长48.99%至83.95%。交易信息汇总资金流向10月17日主力资金净流出590.69万元；游资资金净流入26.21万元；散户资金净流入564.48万元。业绩披露要点业绩预告金石亚药发布业绩预告，预计2025年1-9月归属净利润盈利8660.55万元至1.07亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000001180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"gpt_icon":0},{"id":"2576110080","title":"金石亚药(300434.SZ)发预增，预计前三季度净利润8660.55万元至1.07亿元，同比增长48.99%至83.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576110080","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576110080?lang=zh_cn&edition=full","pubTime":"2025-10-17 17:14","pubTimestamp":1760692485,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)披露2025年前三季度业绩预告，公司预计归属于上市公司股东的净利润8660.55万元至1.07亿元，同比增长48.99%至83.95%;扣除非经常性损益后的净利润6912.79万元至8944.88万元，同比增长32.83%至71.88%。报告期，公司通过有效落实预算优化与费用管控等一系列措施，期间费用实现同比下降，保障了公司整体业务的稳健发展;新材料与机械业务板块得益于前期部分研发项目的成功商业化，其收入与毛利额均实现同比改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356404.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金石亚药(300434.SZ)发预增，预计前三季度净利润8660.55万元至1.07亿元，同比增长48.99%至83.95%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300434"],"gpt_icon":0},{"id":"2574196406","title":"股市必读：金石亚药（300434）10月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2574196406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574196406?lang=zh_cn&edition=full","pubTime":"2025-10-10 03:36","pubTimestamp":1760038576,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，金石亚药报收于9.49元，上涨0.42%，换手率1.42%，成交量4.86万手，成交额4582.9万元。董秘最新回复投资者： 公司股价持续低迷，请问公司有无被监管警示、违规立案调查或ST等潜在风险？当日关注点来自交易信息汇总：10月9日主力资金净流出255.24万元，显示主力短期谨慎态度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000003607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300434"],"gpt_icon":0},{"id":"2568459373","title":"金石亚药：不涉及生产PBO材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2568459373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568459373?lang=zh_cn&edition=full","pubTime":"2025-09-17 11:33","pubTimestamp":1758079985,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好：日前市场传闻，公司已经介入“PBO材料表面金属化处理真空镀膜设备”是否属实?该设备、技术主要应用在哪些领域？市场前景如何？金石亚药回复：尊敬的投资者，您好！公司不涉及生产PBO材料，目前正在进行PBO材料表面金属化处理的真空镀膜设备的研发工作。在研项目如果有实质性进展，公司将会严格按照相关要求履行信息披露义务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700016960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0239","300434"],"gpt_icon":0},{"id":"2563067554","title":"股市必读：金石亚药中报 - 第二季度单季净利润同比增长105.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563067554","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563067554?lang=zh_cn&edition=full","pubTime":"2025-08-29 06:41","pubTimestamp":1756420895,"startTime":"0","endTime":"0","summary":"截至2025年8月28日收盘，金石亚药报收于10.24元，下跌0.97%，换手率5.61%，成交量19.19万手，成交额1.95亿元。来自业绩披露要点：2025年第二季度单季度归母净利润同比上升105.72%，实现显著增长。股本股东变化股东户数变动近日金石亚药披露，截至2025年6月30日公司股东户数为2.28万户，较3月31日增加2799.0户，增幅为14.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900007178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"gpt_icon":0},{"id":"2562746556","title":"金石亚药：2025年上半年净利润同比增长67.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562746556","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562746556?lang=zh_cn&edition=full","pubTime":"2025-08-27 20:11","pubTimestamp":1756296715,"startTime":"0","endTime":"0","summary":"金石亚药公告，2025年上半年营业收入4.92亿元，同比下降5.80%。净利润6574.54万元，同比增长67.71%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/27201152751906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300434"],"gpt_icon":0},{"id":"2555953072","title":"昨日化学制药行业主力净流出超25亿元，金石亚药、九典制药、科伦药业等靠前","url":"https://stock-news.laohu8.com/highlight/detail?id=2555953072","media":"制药网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555953072?lang=zh_cn&edition=full","pubTime":"2025-07-31 11:16","pubTimestamp":1753931766,"startTime":"0","endTime":"0","summary":"2025 年 7 月 30 日，化学制药行业呈现出引人瞩目的资金动态，主力资金流出规模高达 25.19 亿元。其中主力资金净流出靠前的包括金石亚药、九典制药、科伦药业、尔康制药、纳微科技。金石亚药业务涵盖药品和保健食品研发、生产与销售。近日金石亚药公告称，预计2025年1-6月归属于上市公司股东的净利润盈利:5,881.72万元至7,261.78万元,同比上年增长:50.04%至85.24%。近日，九典制药迎来多家机构调研。化学制药行业主力资金的大规模流出，背后原因复杂多样。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073111165994c52f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073111165994c52f17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","LU2148510915.USD","LU1934453819.USD","300434","BK0077","BK0239","LU1064131003.USD","LU1979443071.USD","LU2488822045.USD","LU1064130708.USD","300705","BK0229","688690","BK0028","002422"],"gpt_icon":0},{"id":"2555011179","title":"金石亚药：“快克泰”续断壮骨胶囊为国家中药二类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2555011179","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555011179?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:52","pubTimestamp":1753865577,"startTime":"0","endTime":"0","summary":"有投资者向金石亚药提问， 公司哪个子公司生产创新药公司回答表示，尊敬的投资者，您好！目前，公司主要以品牌仿制药、原料药、中药饮片为主营品种，其中，“快克泰”续断壮骨胶囊为国家中药二类新药。感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730171643a46b4c7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730171643a46b4c7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0077","562390","BK0028","300434","561510"],"gpt_icon":0},{"id":"2555019956","title":"金石亚药：益今生胶囊目前正处于Ⅱ期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2555019956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555019956?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:48","pubTimestamp":1753865298,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)07月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的创新药进展如何了金石亚药回复：尊敬的投资者，您好！公司益今生胶囊目前正处于Ⅱ期临床研究阶段，药品研发周期长、环节多，不确定性因素影响大，敬请您注意投资风险。在研项目如果有实质性进展，公司将会严格按照相关要求履行信息披露义务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000026685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0239","BK0077","BK0028"],"gpt_icon":0},{"id":"2555937019","title":"金石亚药：公司重点产品为“小快克”小儿氨酚黄那敏颗粒","url":"https://stock-news.laohu8.com/highlight/detail?id=2555937019","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555937019?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:48","pubTimestamp":1753865297,"startTime":"0","endTime":"0","summary":"谢谢金石亚药回复：尊敬的投资者，您好！公司重点产品之一为“小快克”小儿氨酚黄那敏颗粒，同时围绕“小快克”品牌，建立了多品种的儿药及儿童补益类保健食品的产品矩阵，如OTC儿药产品“小快克”小儿化痰止咳颗粒、布洛芬颗粒、多维铁口服溶液、赖氨肌醇维B12口服溶液；处方药儿药产品“小快克”阿莫西林颗粒；保健食品“小快克”钙锌维生素D维生素K口服液等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000026684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0239","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765222891925,"stockEarnings":[{"period":"1week","weight":-0.0876},{"period":"1month","weight":0.0043},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.1359},{"period":"1year","weight":0.2256},{"period":"ytd","weight":0.4113}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0184},{"period":"3month","weight":0.0307},{"period":"6month","weight":0.1534},{"period":"1year","weight":0.1528},{"period":"ytd","weight":0.1708}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川金石亚洲医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"23183人(较上一季度增加1.72%)","perCapita":"14757股","listingDate":"2015-04-24","address":"四川省成都市双流区九江镇万家社区","registeredCapital":"40174万元","survey":" 四川金石亚洲医药股份有限公司的主营业务是药品（包括化学药、中药饮片等）和保健食品（包括稀有人参皂苷产品和维生素矿物质补益类产品）的研发、生产与销售；增强塑料复合管道技术的研发和应用、真空镀膜设备的研发和制造。公司的主要产品是药品、保健食品、真空镀膜设备。","listedPrice":10.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金石亚药,300434,金石亚药股票,金石亚药股票老虎,金石亚药股票老虎国际,金石亚药行情,金石亚药股票行情,金石亚药股价,金石亚药股市,金石亚药股票价格,金石亚药股票交易,金石亚药股票购买,金石亚药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}